Tag Archives: Paxlovid

The Price of Paxlovid Deserves Renewed Scrutiny

By | November 22, 2024

Paxlovid is startlingly expensive. As with many drugs in the United States, its pricing deserves renewed scrutiny. Among a handful of approved anti-retrovirals, the drug is the go-to prescription medicine to treat mild-to-moderate COVID-19 in adults. It can reduce the likelihood of ending up in the hospital for people at elevated risk. For older people… Read More »

Selling Fear at a High Price

By | May 23, 2024

I asked the question as a panelist at a health equity gathering, “Who does our health system serve?”. As a family medicine physician who sits perilously between patients and corporations (insurance, pharmaceutical, durable medical equipment, etc.), my answer was quite simple. Our health system serves the profit motives of those with hands in the jar.… Read More »